Kikuchi T, Hashimoto N, Kawasaki T, Kataoka S, Takahashi H, Uchiyama M
Department of Paediatrics, Niigata University School of Medicine, Asahimachi, Japan.
Acta Paediatr. 1998 Aug;87(8):825-9. doi: 10.1080/080352598750013572.
The aim of this study was to reveal the relationship of the plasma levels of the carboxy terminal propeptide of type I procollagen (PICP) and the pyridinoline cross-linked carboxyterminal telopeptide domains of type I collagen (ICTP) to age and height velocity (HV), and to compare PICP and ICTP levels in those who have not reached their final height with those who have. PICP and ICTP levels were measured by RIA in 271 healthy children (161M, 110F) aged from 10 to 15 y. The HV was calculated from their health check-up cards. The subjects were divided into two groups in this study: the final height (FH) group whose HV was <1.0 cm/y, and the non-final height (NFH) group whose HV in the last year was > or =1.0 cm/y. PICP and ICTP levels almost paralleled the values of age-related changes of HV. Furthermore PICP and ICTP levels significantly correlated with HV. PICP and ICTP levels of the FH group were higher than those of adults previously reported. The values will be useful as reference for healthy children and growth disorder. Before reaching final height, PICP and ICTP can be useful makers of not only bone turnover but also of linear growth. Bone turnover rate is still increasingly active just after linear growth has been completed, and then it become similar to the levels of adults.
本研究旨在揭示血浆I型前胶原羧基末端前肽(PICP)和I型胶原吡啶啉交联羧基末端肽(ICTP)水平与年龄及身高增长速度(HV)之间的关系,并比较未达到最终身高者与已达到最终身高者的PICP和ICTP水平。采用放射免疫分析法(RIA)测定了271名年龄在10至15岁的健康儿童(男161名,女110名)的PICP和ICTP水平。HV根据他们的健康体检卡计算得出。本研究将受试者分为两组:HV<1.0 cm/年的最终身高(FH)组和去年HV≥1.0 cm/年的非最终身高(NFH)组。PICP和ICTP水平几乎与HV的年龄相关变化值平行。此外,PICP和ICTP水平与HV显著相关。FH组的PICP和ICTP水平高于先前报道的成年人水平。这些值将作为健康儿童和生长障碍的参考。在达到最终身高之前,PICP和ICTP不仅可作为骨转换的有用指标,也可作为线性生长的指标。在身高线性生长完成后,骨转换率仍然持续活跃,随后变得与成年人水平相似。